Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials.

D'Amico D.

Neurol Sci. 2010 Jun;31 Suppl 1:S23-8. doi: 10.1007/s10072-010-0268-7.

PMID:
20464578
2.

Antiepileptic drugs in migraine prevention.

Mathew NT.

Headache. 2001 Nov-Dec;41 Suppl 1:S18-24. Review.

PMID:
11903536
3.

GABAergic drugs for the treatment of migraine.

Puppe A, Limmroth V.

CNS Neurol Disord Drug Targets. 2007 Aug;6(4):247-50. Review.

PMID:
17691980
4.

[Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].

Pinheiro D.

Encephale. 2008 Sep;34(4):409-15. doi: 10.1016/j.encep.2007.10.006. Epub 2008 Jan 14. Review. French.

PMID:
18922244
5.
6.

Antiepileptic drugs in migraine prophylaxis: state of the art.

Capuano A, Vollono C, Mei D, Pierguidi L, Ferraro D, Di Trapani G.

Clin Ter. 2004 Feb-Mar;155(2-3):79-87. Review.

PMID:
15244112
7.

Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.

He A, Song D, Zhang L, Li C.

J Headache Pain. 2017 Dec;18(1):26. doi: 10.1186/s10194-017-0720-7. Epub 2017 Feb 20.

8.

Cost-effectiveness of antiepileptic drugs in migraine prophylaxis.

Adelman JU, Adelman LC, Von Seggern R.

Headache. 2002 Nov-Dec;42(10):978-83.

PMID:
12453029
9.

Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study.

Di Trapani G, Mei D, Marra C, Mazza S, Capuano A.

Clin Ter. 2000 May-Jun;151(3):145-8.

PMID:
10958046
10.

Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms.

Calabresi P, Galletti F, Rossi C, Sarchielli P, Cupini LM.

Trends Pharmacol Sci. 2007 Apr;28(4):188-95. Epub 2007 Mar 6. Review.

PMID:
17337068
11.

Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.

Bussone G, Usai S, D'Amico D.

Neurol Sci. 2006 May;27 Suppl 2:S159-63. Review.

PMID:
16688622
12.

Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.

Shaygannejad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V.

Headache. 2006 Apr;46(4):642-8.

PMID:
16643559
13.

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201(TOP-CHROME) Study Group.

Cephalalgia. 2007 Jul;27(7):814-23. Epub 2007 Apr 18. Erratum in: Cephalalgia. 2007 Aug;27(8):962.

PMID:
17441971
14.

[Valproic acid in prophylactic treatment of migraine].

Arnold G, Einhäupl KM.

Nervenarzt. 1998 Oct;69(10):913-8. Review. German.

PMID:
9834484
15.

[Antiepileptic drugs for the prevention of pediatric migraine].

Cuvellier JC.

Rev Neurol (Paris). 2009 Dec;165(12):1002-9. doi: 10.1016/j.neurol.2009.01.050. Review. French.

PMID:
19345966
16.

The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.

Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L.

Health Qual Life Outcomes. 2007 Oct 4;5:56.

17.

[The role of the neuromodulators in the preventive treatment of migraine].

Pascual-Gómez J.

Rev Neurol. 2009 Jul 1-15;49(1):25-32. Spanish.

18.

Gabapentin for the prophylaxis of episodic migraine in adults.

Fogleman CD.

Am Fam Physician. 2014 May 1;89(9):714-5. Review. No abstract available.

19.

Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.

Bussone G, Diener HC, Pfeil J, Schwalen S.

Int J Clin Pract. 2005 Aug;59(8):961-8.

PMID:
16033621
20.

The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.

Chengappa KN, Gershon S, Levine J.

Bipolar Disord. 2001 Oct;3(5):215-32. Review.

PMID:
11912568

Supplemental Content

Support Center